Yale researchers have developed an oral medication to treat diabetes that controls insulin levels while simultaneously reversing the inflammatory effects of the disease.
Developed by Tarek Fahmy, associate professor of biomedical engineering and of immunobiology, the drug has two critical advantages over the standard treatment for diabetes. Because it can be taken orally, it’s much simpler for the patient to stay compliant with his or her treatment. It also addresses three major issues with diabetes at the same time: it helps control immediate blood glucose levels, restores pancreatic function, and re-establishes normal immunity in the pancreatic environment.
Image: Because it can be taken orally, it’s much simpler for the patient to stay compliant with his or her treatment. (CREDIT: Creative Commons)